Selected research
Industry Growth & Trends
Global Valbenazine Industry Growth and Trends Forecast to 2032
Market perspective
The global Valbenazine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Valbenazine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Valbenazine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Valbenazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Valbenazine include Vcare Pharmatech, Toronto Research Chemicals, TargetMol, Neurocrine Biosciences, Clearsynth, BOC Sciences and Adooq Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Valbenazine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Valbenazine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Valbenazine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Valbenazine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Valbenazine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Valbenazine Market by Company
Vcare Pharmatech
Toronto Research Chemicals
TargetMol
Neurocrine Biosciences
Clearsynth
BOC Sciences
Adooq Bioscience
Valbenazine Segment by Type
40mg Capsule
60mg Capsule
80mg Capsule
Valbenazine Segment by Application
Tardive Dyskinesia
Tourette Syndrome
Valbenazine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valbenazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valbenazine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valbenazine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Valbenazine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Valbenazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 40mg Capsule
- 60mg Capsule
- 80mg Capsule
Applications
- Tardive Dyskinesia
- Tourette Syndrome
Companies covered
- Vcare Pharmatech
- Toronto Research Chemicals
- TargetMol
- Neurocrine Biosciences
- Clearsynth
- BOC Sciences
- Adooq Bioscience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Valbenazine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Valbenazine Sales Estimates and Forecasts (2021-2032)
- 1.3 Valbenazine Market by Type
- 1.3.1 40mg Capsule
- 1.3.2 60mg Capsule
- 1.3.3 80mg Capsule
- 1.4 Global Valbenazine Market Size by Type
- 1.4.1 Global Valbenazine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Valbenazine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Valbenazine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Valbenazine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Valbenazine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Valbenazine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Valbenazine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Valbenazine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Valbenazine Industry Trends
- 2.2 Valbenazine Industry Drivers
- 2.3 Valbenazine Industry Opportunities and Challenges
- 2.4 Valbenazine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Valbenazine Revenue (2021-2026)
- 3.2 Global Top Players by Valbenazine Sales (2021-2026)
- 3.3 Global Top Players by Valbenazine Price (2021-2026)
- 3.4 Global Valbenazine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Valbenazine Major Company Production Sites & Headquarters
- 3.6 Global Valbenazine Company, Product Type & Application
- 3.7 Global Valbenazine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Valbenazine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Valbenazine Players Market Share by Revenue in 2025
- 3.8.3 2025 Valbenazine Tier 1, Tier 2, and Tier 3
4 Valbenazine Regional Status and Outlook
- 4.1 Global Valbenazine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Valbenazine Historic Market Size by Region
- 4.2.1 Global Valbenazine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Valbenazine Sales in Value by Region (2021-2026)
- 4.2.3 Global Valbenazine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Valbenazine Forecasted Market Size by Region
- 4.3.1 Global Valbenazine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Valbenazine Sales in Value by Region (2027-2032)
- 4.3.3 Global Valbenazine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Valbenazine by Application
- 5.1 Valbenazine Market by Application
- 5.1.1 Tardive Dyskinesia
- 5.1.2 Tourette Syndrome
- 5.2 Global Valbenazine Market Size by Application
- 5.2.1 Global Valbenazine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Valbenazine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Valbenazine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Valbenazine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Valbenazine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Valbenazine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Valbenazine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Valbenazine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Vcare Pharmatech
- 6.1.1 Vcare Pharmatech Company Information
- 6.1.2 Vcare Pharmatech Business Overview
- 6.1.3 Vcare Pharmatech Valbenazine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Vcare Pharmatech Valbenazine Product Portfolio
- 6.1.5 Vcare Pharmatech Recent Developments
- 6.2 Toronto Research Chemicals
- 6.2.1 Toronto Research Chemicals Company Information
- 6.2.2 Toronto Research Chemicals Business Overview
- 6.2.3 Toronto Research Chemicals Valbenazine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Toronto Research Chemicals Valbenazine Product Portfolio
- 6.2.5 Toronto Research Chemicals Recent Developments
- 6.3 TargetMol
- 6.3.1 TargetMol Company Information
- 6.3.2 TargetMol Business Overview
- 6.3.3 TargetMol Valbenazine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 TargetMol Valbenazine Product Portfolio
- 6.3.5 TargetMol Recent Developments
- 6.4 Neurocrine Biosciences
- 6.4.1 Neurocrine Biosciences Company Information
- 6.4.2 Neurocrine Biosciences Business Overview
- 6.4.3 Neurocrine Biosciences Valbenazine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Neurocrine Biosciences Valbenazine Product Portfolio
- 6.4.5 Neurocrine Biosciences Recent Developments
- 6.5 Clearsynth
- 6.5.1 Clearsynth Company Information
- 6.5.2 Clearsynth Business Overview
- 6.5.3 Clearsynth Valbenazine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Clearsynth Valbenazine Product Portfolio
- 6.5.5 Clearsynth Recent Developments
- 6.6 BOC Sciences
- 6.6.1 BOC Sciences Company Information
- 6.6.2 BOC Sciences Business Overview
- 6.6.3 BOC Sciences Valbenazine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 BOC Sciences Valbenazine Product Portfolio
- 6.6.5 BOC Sciences Recent Developments
- 6.7 Adooq Bioscience
- 6.7.1 Adooq Bioscience Company Information
- 6.7.2 Adooq Bioscience Business Overview
- 6.7.3 Adooq Bioscience Valbenazine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Adooq Bioscience Valbenazine Product Portfolio
- 6.7.5 Adooq Bioscience Recent Developments
7 North America by Country
- 7.1 North America Valbenazine Sales by Country
- 7.1.1 North America Valbenazine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Valbenazine Sales by Country (2021-2026)
- 7.1.3 North America Valbenazine Sales Forecast by Country (2027-2032)
- 7.2 North America Valbenazine Market Size by Country
- 7.2.1 North America Valbenazine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Valbenazine Market Size by Country (2021-2026)
- 7.2.3 North America Valbenazine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Valbenazine Sales by Country
- 8.1.1 Europe Valbenazine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Valbenazine Sales by Country (2021-2026)
- 8.1.3 Europe Valbenazine Sales Forecast by Country (2027-2032)
- 8.2 Europe Valbenazine Market Size by Country
- 8.2.1 Europe Valbenazine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Valbenazine Market Size by Country (2021-2026)
- 8.2.3 Europe Valbenazine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Valbenazine Sales by Country
- 9.1.1 Asia-Pacific Valbenazine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Valbenazine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Valbenazine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Valbenazine Market Size by Country
- 9.2.1 Asia-Pacific Valbenazine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Valbenazine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Valbenazine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Valbenazine Sales by Country
- 10.1.1 South America Valbenazine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Valbenazine Sales by Country (2021-2026)
- 10.1.3 South America Valbenazine Sales Forecast by Country (2027-2032)
- 10.2 South America Valbenazine Market Size by Country
- 10.2.1 South America Valbenazine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Valbenazine Market Size by Country (2021-2026)
- 10.2.3 South America Valbenazine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Valbenazine Sales by Country
- 11.1.1 Middle East and Africa Valbenazine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Valbenazine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Valbenazine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Valbenazine Market Size by Country
- 11.2.1 Middle East and Africa Valbenazine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Valbenazine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Valbenazine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Valbenazine Value Chain Analysis
- 12.1.1 Valbenazine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Valbenazine Production Mode & Process
- 12.2 Valbenazine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Valbenazine Distributors
- 12.2.3 Valbenazine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst